Xin Feng
Research Subjects
Xin Feng has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Lianghai Hu
Center for Supramolecular Chemical Biology, State Key Laboratory of Supramolecular Structure and Materials, School of Life Sciences, Jilin University, Changchun 130023, China
6 shared publications - Yuling Wang
School of Natural Sciences, Faculty of Science and Engineering, Macquarie University, Sydney, Australia
4 shared publications Shengnan Jia
Center for Supramolecular Chemical Biology, State Key Laboratory of Supramolecular Structure and Materials, School of Life Sciences, Jilin University, Changchun, China
3 shared publicationsSimon Chang-Hao Tsao
School of Natural Sciences, Faculty of Science and Engineering
3 shared publications- Cao Hoang Long Ngo
School of Natural Sciences Faculty of Science and Engineering Macquarie University Sydney NSW 2109 Australia
2 shared publications Chao Shen
Macquarie Analytical & Fabrication Facility, Faculty of Science and Engineering
2 shared publications
Latest Publications
- 19 January 2026
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 25 (2) , 1139-1151
Proteomics Study of Breast Cancer-Derived Small Extracellular Vesicles: Unveiling Potential Cancer Biomarkers
Small extracellular vesicles (sEVs) are lipid-bilayer-enclosed vesicles secreted by cells into the extracellular environment, carrying a variety of biomolecules, including proteins that reflect the molecular profile of their cell of origin. In particular, cancer-derived sEVs hold significant potential for cancer diagnosis due to their unique biomolecular content. In this study, we utilized mass spectrometry to profile the protein expression in plasma-derived sEVs from both healthy controls (HCs) and breast cancer (BC) patients with the aim of discovering new protein biomarkers for potential BC diagnosis. Through the cross-validation of differentially expressed proteins between the two independent cohorts, we identified nine proteins that were significantly upregulated in BC-derived sEVs. Further validation using online gene expression data sets, Western blot, and ELISA revealed that OIT3 was upregulated in BC tissue compared to HC tissue, suggesting its potential as a novel BC biomarker. These findings contribute to advancing the knowledge of proteins within sEVs, as well as offering promising avenues for the use of sEVs as biomarkers in future cancer diagnostic applications.
- 19 January 2026
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 25 (2) , 1139-1151
Proteomics Study of Breast Cancer-Derived Small Extracellular Vesicles: Unveiling Potential Cancer Biomarkers
Small extracellular vesicles (sEVs) are lipid-bilayer-enclosed vesicles secreted by cells into the extracellular environment, carrying a variety of biomolecules, including proteins that reflect the molecular profile of their cell of origin. In particular, cancer-derived sEVs hold significant potential for cancer diagnosis due to their unique biomolecular content. In this study, we utilized mass spectrometry to profile the protein expression in plasma-derived sEVs from both healthy controls (HCs) and breast cancer (BC) patients with the aim of discovering new protein biomarkers for potential BC diagnosis. Through the cross-validation of differentially expressed proteins between the two independent cohorts, we identified nine proteins that were significantly upregulated in BC-derived sEVs. Further validation using online gene expression data sets, Western blot, and ELISA revealed that OIT3 was upregulated in BC tissue compared to HC tissue, suggesting its potential as a novel BC biomarker. These findings contribute to advancing the knowledge of proteins within sEVs, as well as offering promising avenues for the use of sEVs as biomarkers in future cancer diagnostic applications.
- 25 October 2025
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 10 (11) , 8885-8894
Photonic Crystal-Enhanced Surface-Enhanced Raman Scattering Biosensor with an Amphipathic Dendritic Supermolecule Probe for Direct Plasma Exosome Detection
Exosomes hold great promise for tumor diagnosis, but their efficient isolation and sensitive in situ detection from biofluids remain challenging. Surface-enhanced Raman scattering (SERS) is an ideal solution due to its high sensitivity, yet conventional SERS biosensors face a trade-off between complex nanostructures for strong hotspots and practical fabrication. Here, we developed a novel strategy combining a highly stable large-sized opal photonic crystal (OPC) substrate with an amphipathic dendritic supermolecule probe (ADSP) for exosome capture and detection. The OPC substrate enhances SERS performance by modulating incident light, enabling a simple Au nanolayer to achieve detection limits as low as 1 × 10-9 M. Meanwhile, ADSP ensures efficient exosome capture from plasma. Together, this approach allows direct isolation and sensitive in situ detection using a structurally simple device. Significant differences between patient and healthy donor groups were observed in practical sample detection, highlighting the potential of this exosome capture and detection platform for clinical applications.
- 25 October 2025
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 10 (11) , 8885-8894
Photonic Crystal-Enhanced Surface-Enhanced Raman Scattering Biosensor with an Amphipathic Dendritic Supermolecule Probe for Direct Plasma Exosome Detection
Exosomes hold great promise for tumor diagnosis, but their efficient isolation and sensitive in situ detection from biofluids remain challenging. Surface-enhanced Raman scattering (SERS) is an ideal solution due to its high sensitivity, yet conventional SERS biosensors face a trade-off between complex nanostructures for strong hotspots and practical fabrication. Here, we developed a novel strategy combining a highly stable large-sized opal photonic crystal (OPC) substrate with an amphipathic dendritic supermolecule probe (ADSP) for exosome capture and detection. The OPC substrate enhances SERS performance by modulating incident light, enabling a simple Au nanolayer to achieve detection limits as low as 1 × 10-9 M. Meanwhile, ADSP ensures efficient exosome capture from plasma. Together, this approach allows direct isolation and sensitive in situ detection using a structurally simple device. Significant differences between patient and healthy donor groups were observed in practical sample detection, highlighting the potential of this exosome capture and detection platform for clinical applications.
- 14 October 2025
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 25 (42) , 15331-15339
Integrated Chemical Array and SERS Profiling of Plasma Small Extracellular Vesicles for Breast Cancer Diagnosis
Small extracellular vesicles (sEVs) are nanoscale vesicles carrying biomolecules reflective of their cellular origin, making them attractive biomarkers for cancer diagnosis. In this study, we present a high-throughput strategy integrating amphiphile-dendrimer supramolecular probe (ADSP)-based sEV capture with surface-enhanced Raman scattering (SERS) for sensitive, multiplexed detection of breast cancer (BC)-related surface proteins. Plasma-derived sEVs from BC patients at different clinical stages were analyzed, focusing on CD9, EpCAM, and HER2 as key proteins linked to vesicle identity and tumor progression. Gold nanoparticle-based SERS nanotags conjugated with specific antibodies enabled precise detection. Statistical and machine learning analyses of protein profiles allowed accurate discrimination among healthy donors, ductal carcinoma in situ (Stage 0), early stage BC (Stage I-II), and metastatic-stage BC (Stage IV). This integrated platform provides a powerful tool for BC diagnosis and highlights the potential of sEV-based liquid biopsy strategies for clinical application.
- 14 October 2025
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 25 (42) , 15331-15339
Integrated Chemical Array and SERS Profiling of Plasma Small Extracellular Vesicles for Breast Cancer Diagnosis
Small extracellular vesicles (sEVs) are nanoscale vesicles carrying biomolecules reflective of their cellular origin, making them attractive biomarkers for cancer diagnosis. In this study, we present a high-throughput strategy integrating amphiphile-dendrimer supramolecular probe (ADSP)-based sEV capture with surface-enhanced Raman scattering (SERS) for sensitive, multiplexed detection of breast cancer (BC)-related surface proteins. Plasma-derived sEVs from BC patients at different clinical stages were analyzed, focusing on CD9, EpCAM, and HER2 as key proteins linked to vesicle identity and tumor progression. Gold nanoparticle-based SERS nanotags conjugated with specific antibodies enabled precise detection. Statistical and machine learning analyses of protein profiles allowed accurate discrimination among healthy donors, ductal carcinoma in situ (Stage 0), early stage BC (Stage I-II), and metastatic-stage BC (Stage IV). This integrated platform provides a powerful tool for BC diagnosis and highlights the potential of sEV-based liquid biopsy strategies for clinical application.
- 22 October 2024
- Published by Springer Nature in Nature Protocols
- Vol. 20 (4) , 1057-1081
High-throughput capture and in situ protein analysis of extracellular vesicles by chemical probe-based array
Extracellular vesicles (EVs) are small particles with phospholipid bilayers that carry a diverse range of cargoes including nucleic acids, proteins and metabolites. EVs have important roles in various cellular processes and are increasingly recognized for their ubiquitous role in cell–cell communications and potential applications in therapeutics and diagnostics. Although many methods have been developed for the characterization and measurement of EVs, analyzing them from biofluids remains a challenge with regard to throughput and sensitivity. Recently, we introduced an approach to facilitate high-throughput analysis of EVs from trace amounts of sample. In this method, an amphiphile–dendrimer supramolecular probe (ADSP) is coated onto a nitrocellulose membrane for array-based capture and to enable an in situ immunoblotting assay. Here, we describe the protocol for our array-based method of EV profiling. We describe an enhanced version of the method that incorporates an automated printing workstation, ensuring high throughput and reproducibility. We further demonstrate the use of our array to profile specific glycosylations on the EV surface using click chemistry of an azide group introduced by metabolic labeling. In this protocol, the synthesis of ADSP and the fabrication of ADSP nitrocellulose membrane array can be completed on the same day. EVs are efficiently captured from biological or clinical samples through a 30-min incubation, followed by an immunoblotting assay within a 3-h window, thus providing a high-throughput platform for EV isolation and in situ targeted analysis of EV proteins and their modifications.
- 22 October 2024
- Published by Springer Nature in Nature Protocols
- Vol. 20 (4) , 1057-1081
High-throughput capture and in situ protein analysis of extracellular vesicles by chemical probe-based array
Extracellular vesicles (EVs) are small particles with phospholipid bilayers that carry a diverse range of cargoes including nucleic acids, proteins and metabolites. EVs have important roles in various cellular processes and are increasingly recognized for their ubiquitous role in cell–cell communications and potential applications in therapeutics and diagnostics. Although many methods have been developed for the characterization and measurement of EVs, analyzing them from biofluids remains a challenge with regard to throughput and sensitivity. Recently, we introduced an approach to facilitate high-throughput analysis of EVs from trace amounts of sample. In this method, an amphiphile–dendrimer supramolecular probe (ADSP) is coated onto a nitrocellulose membrane for array-based capture and to enable an in situ immunoblotting assay. Here, we describe the protocol for our array-based method of EV profiling. We describe an enhanced version of the method that incorporates an automated printing workstation, ensuring high throughput and reproducibility. We further demonstrate the use of our array to profile specific glycosylations on the EV surface using click chemistry of an azide group introduced by metabolic labeling. In this protocol, the synthesis of ADSP and the fabrication of ADSP nitrocellulose membrane array can be completed on the same day. EVs are efficiently captured from biological or clinical samples through a 30-min incubation, followed by an immunoblotting assay within a 3-h window, thus providing a high-throughput platform for EV isolation and in situ targeted analysis of EV proteins and their modifications.
- 11 October 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (42) , 56874-56883
Preparation of Dysprosium(III)-Metal Organic Framework Nanofiber for Exosome Capture and Biomarker Discovery toward Liver Disease
As an emerging source for liquid biopsy, exosomes hold significant promise for clinical diagnosis. However, commonly used exosome isolation methods (e.g., ultracentrifugation) suffer from low throughput for a large number of clinical samples. Herein, a dysprosium-metal organic framework was synthesized and doped with nanofibers by electrospinning for efficient capture of exosomes from body fluid. With the integration of multichannel of pipet or robot automatic workstation, high throughput exosome isolation can be achieved with clinical samples with high reproducibility. To evaluate the clinical value of the developed method, urinary exosomes were enriched from 34 liver disease samples of different stages for the profiling of metabolites by mass spectrometry. The results showed that HCC, cirrhosis, and healthy controls can be significantly differentiated by the Random Forest classification model. The dysprosium-metal organic framework has promising applications in exosome-based liquid biopsy for large-scale clinical disease diagnosis.
- 11 October 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (42) , 56874-56883
Preparation of Dysprosium(III)-Metal Organic Framework Nanofiber for Exosome Capture and Biomarker Discovery toward Liver Disease
As an emerging source for liquid biopsy, exosomes hold significant promise for clinical diagnosis. However, commonly used exosome isolation methods (e.g., ultracentrifugation) suffer from low throughput for a large number of clinical samples. Herein, a dysprosium-metal organic framework was synthesized and doped with nanofibers by electrospinning for efficient capture of exosomes from body fluid. With the integration of multichannel of pipet or robot automatic workstation, high throughput exosome isolation can be achieved with clinical samples with high reproducibility. To evaluate the clinical value of the developed method, urinary exosomes were enriched from 34 liver disease samples of different stages for the profiling of metabolites by mass spectrometry. The results showed that HCC, cirrhosis, and healthy controls can be significantly differentiated by the Random Forest classification model. The dysprosium-metal organic framework has promising applications in exosome-based liquid biopsy for large-scale clinical disease diagnosis.
- 1 May 2023
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 22 (7) , 2516-2524
Proteomic Discovery and Array-Based Validation of Biomarkers from Urinary Exosome by Supramolecular Probe
Exosomes are nanoscale, membrane-enclosed vesicles with contents similar to their parent cells, which are rich in potential biomarkers. Urine, as a noninvasive sampling body fluid, has the advantages of being simple to collect, stable in protein, diverse and not regulated by homeostatic mechanisms of the body, making it a favorable target for studying tumor biomarkers. In this report, the urinary exosomal proteome was analyzed and high-throughput downstream validation was performed using a supramolecular probe-based capture and in situ detection. The technology demonstrated the efficient enrichment of exosomes with a high concentration (5.5 × 1010 particles/mL) and a high purity (2.607 × 1010 particles/mg) of exosomes from urine samples. Proteomic analysis of urine samples from patients with hepatocellular carcinoma and healthy individuals combined with proteomic screening techniques revealed that 68 proteins were up-regulated in patients with hepatocellular carcinoma. As a proof-of-principle study, three of these differentially expressed proteins, including OLFM4, HDGF and GDF15, were validated using the supramolecular probe-based array (48 samples per batch). These findings demonstrate the great potential of this approach toward a liquid biopsy for the discovery and validation of biomarkers from urinary exosomes, and it can be extended to various biological samples with lower content of exosomes.
- 1 May 2023
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 22 (7) , 2516-2524
Proteomic Discovery and Array-Based Validation of Biomarkers from Urinary Exosome by Supramolecular Probe
Exosomes are nanoscale, membrane-enclosed vesicles with contents similar to their parent cells, which are rich in potential biomarkers. Urine, as a noninvasive sampling body fluid, has the advantages of being simple to collect, stable in protein, diverse and not regulated by homeostatic mechanisms of the body, making it a favorable target for studying tumor biomarkers. In this report, the urinary exosomal proteome was analyzed and high-throughput downstream validation was performed using a supramolecular probe-based capture and in situ detection. The technology demonstrated the efficient enrichment of exosomes with a high concentration (5.5 × 1010 particles/mL) and a high purity (2.607 × 1010 particles/mg) of exosomes from urine samples. Proteomic analysis of urine samples from patients with hepatocellular carcinoma and healthy individuals combined with proteomic screening techniques revealed that 68 proteins were up-regulated in patients with hepatocellular carcinoma. As a proof-of-principle study, three of these differentially expressed proteins, including OLFM4, HDGF and GDF15, were validated using the supramolecular probe-based array (48 samples per batch). These findings demonstrate the great potential of this approach toward a liquid biopsy for the discovery and validation of biomarkers from urinary exosomes, and it can be extended to various biological samples with lower content of exosomes.